GLP-1 RAs, such as Ozempic and Wegovy, are medications that mimic this hormone
Studies show that liraglutide 3.0 mg reduces gastric emptying by 23% at the 1-hour mark compared to placebo, while lower doses show a 13% decrease
The exact dose depends on your weight, comorbidities, kidney function, and disease activity, and should always be determined by your prescribing physician
Understanding what to expect and how to respond enables most users to continue treatment through temporary discomfort that resolves with time
Conclusion: Retatrutide Safety Outlook Retatrutide continues to generate interest as a potential future option for weight management, but its complete safety profile is still being established through ongoing research
Sarcopenic obesity (SO) is defined as the coexistence of excess adiposity combined with loss of muscle mass and function, representing a significant public health issue in the geriatric population [2]